In contrast, experimental evidence suggested that IFN-α treatment of P. berghei-infected mice has a protective effect on the evolution of cerebral malaria and inhibits the development of P. yoelli blood-stage infections in mice [35], [36]. This evidence concerns the gene IFNA2 and infection.